Form 8-K - Current report:
SEC Accession No. 0001193125-21-192105
Filing Date
2021-06-16
Accepted
2021-06-16 16:05:55
Documents
12
Period of Report
2021-06-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K d191137d8k.htm   iXBRL 8-K 25870
  Complete submission text file 0001193125-21-192105.txt   153096

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sldb-20210615.xsd EX-101.SCH 3069
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sldb-20210615_lab.xml EX-101.LAB 18887
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sldb-20210615_pre.xml EX-101.PRE 11859
5 EXTRACTED XBRL INSTANCE DOCUMENT d191137d8k_htm.xml XML 3475
Mailing Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139
Business Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38360 | Film No.: 211021545
SIC: 2836 Biological Products, (No Diagnostic Substances)